Fig. 7: Schematic representation of radiolabeled small molecule in prostate cancer therapy.
From: Carrier systems of radiopharmaceuticals and the application in cancer therapy
a 177Lu-PSMA-617 for the treatment of prostate cancer. b Radiolabeled small molecules, heterodimers of small molecules linked to peptides, small molecule-modified NPs for prostate cancer therapy. c Novel strategies targeting PSMA for prostate cancer therapy.
